| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/01/2002 | US20020103228 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
| 08/01/2002 | US20020103226 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 08/01/2002 | US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors |
| 08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | US20020103189 Nitrogen-containing tricyclic compounds and drugs containing the same |
| 08/01/2002 | US20020103185 Pyrazole derivatives |
| 08/01/2002 | US20020102608 Library of indolinone compounds for use in the treatment of cancer |
| 08/01/2002 | US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2435143A1 Halogen compounds having thrombopoietin receptor agonism |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 08/01/2002 | CA2421583A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents |
| 07/31/2002 | EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials |
| 07/31/2002 | EP1226142A2 Process for the production of epothiolone b and derivatives as well as intermediate products for this process |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226136A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP0883611B1 Azolyl piperazinyl phenyl oxazolidinone antimicrobials |
| 07/31/2002 | CN1361775A Novel diphenyl-piperidine derivate |
| 07/31/2002 | CN1361771A Process for the preparation of substituted benzisothiazole compounds |
| 07/31/2002 | CN1361770A Heteroaromatic ring compounds |
| 07/31/2002 | CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one |
| 07/31/2002 | CN1361693A Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance |
| 07/31/2002 | CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema |
| 07/30/2002 | US6426408 Plurality of nucleotide units with linking group |
| 07/30/2002 | US6426357 Antagonists of follicle stimulating hormone activity |
| 07/30/2002 | US6426356 Analgesics; hypotensive agents; antidepressants |
| 07/30/2002 | US6426344 Aryl and heteroaryl substituted indolealkanoic acids |
| 07/30/2002 | CA2214138C An agricultural and horticultural disease controller and a method for controlling the diseases |
| 07/25/2002 | WO2002057261A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057249A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057244A1 Phenothiazine kinesin inhibitors |
| 07/25/2002 | WO2002057240A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2002050061A8 Piperazine derivatives for treatment of bacterial infections |
| 07/25/2002 | WO2002042268A3 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002030867A3 Drugs for diabetes |
| 07/25/2002 | WO2002006229A3 Heterocyclic beta-3 adrenergic receptor agonists |
| 07/25/2002 | WO2001090091A8 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/25/2002 | US20020099217 Process for preparing azacycloalkanoylaminothiazoles |
| 07/25/2002 | US20020099214 For prophylaxis and therapy of pruritus |
| 07/25/2002 | US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 07/25/2002 | US20020099081 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 07/25/2002 | DE10130830A1 Indol-Derivate Indole derivatives |
| 07/25/2002 | CA2435117A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2434296A1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | CA2432870A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/24/2002 | EP1225169A1 Radiation-activated cytotoxin therapy |
| 07/24/2002 | EP1224316A2 13-alkyl epothilone derivatives |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | EP1224185A1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224169A2 Production of 5-substituted indolinones and use thereof as medicaments |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP0946203B1 Tricyclic functional dyes for contrast enhancement in optical imaging |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/24/2002 | CN1359899A Saccharin deriv. |
| 07/24/2002 | CN1088063C Sulfmidyl (thio) carbonyl-1,2,4-triazolineone deriv. and preparation method and application as weed killer |
| 07/24/2002 | CN1087936C Use of thiadiazole and oxadiazole derivs. in preparing antipsychotic medicine |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423709 Methods of using novel compounds as neuro-protective agents |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423707 Nitroimidazole ester analogues and therapeutic applications |
| 07/23/2002 | US6423519 Contacting fungal cell with compound which inhibits prenyltransferase activity of cell, including permease tag which facilitates permease-mediated transport of compound into cell, inhibiting growth thereof |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055497A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002055078A2 Use of chromanes for treating parkinson's disease |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | US20020095039 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/18/2002 | US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |